According to an article posted by the Yale School of Medicine in July 2024, “The first drug in a class known as GLP-1 ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of an array of ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

According to PR Newswire, Novo Nordisk said the pill is also approved to help reduce the risk of major cardiovascular events, ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump speaks during an event on ...

President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Watch in our video player above. Pharmaceutical companies Amgen, ...

President Trump said the administration has reached agreements with nine more drugmakers to bring their U.S. drug prices more in line with what other wealthy countries pay. Fourteen companies in total ...

President Trump on Friday announced new agreements with nine pharmaceutical manufacturers aimed at reducing certain prescription drug prices. "Starting next year, American drug prices will come down ...

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, ...